TRK-100STP , a sustained release tablet of an orally-active prostacyclin analogue , beraprost sodium , is suggested to suppress worsening of some parameters of renal filtration function , containing in slope of 1/serum creatinine ( 1/SCr ) vs. time in a phase II clinical trial .